{
    "root": "21306af5-e07a-4f8e-8f59-3e0aacc53102",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "BELSOMRA",
    "value": "20250310",
    "ingredients": [
        {
            "name": "suvorexant",
            "code": "081L192FO9"
        },
        {
            "name": "COPOVIDONE K25-31",
            "code": "D9C330MD8B"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "lactose monohydrate",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "croscarmellose sodium",
            "code": "M28OL1HH48"
        },
        {
            "name": "magnesium stearate",
            "code": "70097M6I30"
        },
        {
            "name": "titanium dioxide",
            "code": "15FIX9V2JP"
        },
        {
            "name": "triacetin",
            "code": "XHX3C3X673"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        }
    ],
    "indications": "belsomra\u00ae ( suvorexant ) indicated treatment insomnia characterized difficulties sleep onset and/or sleep maintenance .",
    "contraindications": "lowest dose effective patient ( 2.1 ) . recommended dose 10 mg , per night taken within 30 minutes going bed , least 7 hours remaining planned time awakening . 10 mg dose well-tolerated effective , dose increased , exceed 20 mg daily ( 2.1 , 2.2 ) . time effect may delayed taken soon meal ( 2.1 ) .",
    "warningsAndPrecautions": null,
    "adverseReactions": "belsomra contraindicated patients narcolepsy .",
    "indications_original": "BELSOMRA\u00ae (suvorexant) is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.",
    "contraindications_original": "Use the lowest dose effective for the patient ( 2.1 ). Recommended dose is 10 mg, no more than once per night taken within 30 minutes of going to bed, with at least 7 hours remaining before the planned time of awakening. If the 10 mg dose is well-tolerated but not effective, the dose can be increased, not to exceed 20 mg once daily ( 2.1 , 2.2 ). Time to effect may be delayed if taken with or soon after a meal ( 2.1 ).",
    "adverseReactions_original": "BELSOMRA is contraindicated in patients with narcolepsy."
}